Hosted for its second year, LifeSciences BC's Access to Innovation Conference will bring together health and life sciences stakeholders to present, discuss and deliver meaningful ways to culitivate collaboration, develop and deliver innovation, while improving outcomes and saving healthcare cost.
Keynote Speakers: Hon. Dr. Andrew Wilkinson, Minister of Advanced Education & Hon. Amrik Virk, Minister of Technology, Innovation & Citizens' Services
Confirmed Presenters: Dr. Jane Aubin, Dr. Robert McMaster, Dr. Brendan Byrne, Dr. David Castle, Dr. Heather Davidson, Dr. Bettina Hamelin, Dr. Simon Sutcliffe, Dr. Gavin Stuart, Dr. Sue Collier and Dr. Leslie Alexander, CEO & President, Life Sciences Washington
Evonik strengthens its position as a leading service provider for parenteral drug delivery technologies
September 26, 2016 - Essen, Germany. The end of August marked the completion of the acquisition of biotechnology company Transferra Nanosciences Inc., formerly known as Northern Lipids Inc., further strengthening Evonik's Health Care Business Line's position as a leading provider of services for the development of drug delivery systems.
Equicare Health highlights the value of patient engagement at ASTRO 2016 through partnership with The Samfund
Vancouver, BC - September 25, 2016 - Equicare Health Inc. announces that the company will demonstrate their oncology patient engagement software at the ASTRO 2016 Annual Meeting in Boston starting today.
Xenon Pharmaceuticals Appoints Dawn Svoronos to Its Board of Directors
BURNABY, British Columbia, Sept. 27, 2016 (GLOBE NEWSWIRE) - Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a clinical-stage biopharmaceutical company, today announced that Dawn Svoronos has been appointed to its Board of Directors. Ms. Svoronos is a pharmaceutical industry executive whose experience includes a 23-year career at Merck & Co. with a focus on commercial operations and marketing, as well as board positions at Medivation Inc. and Theratechnologies Inc.
GenomeDx and SouthGenetics Announce Strategic Agreement for Latin America Commercialization
San Diego - Sept. 28, 2016 - GenomeDx Biosciences and SouthGenetics Inc. today announced that they have signed a strategic agreement to bring GenomeDx's Decipher® Prostate Cancer Classifier Tests to several Latin American countries, including Mexico, Argentina, Colombia and Uruguay. SouthGenetics has established itself as a leader in the introduction of new diagnostic techniques to the Latin America market.
Zymeworks and Daiichi Sankyo Announce Immuno-Oncology Cross-Licensing Agreement and Bi-Specific Antibody Collaboration
Vancouver, Canada, Tokyo, Japan and Parsippany, NJ (September 28, 2016) - Zymeworks Inc., a clinical-stage biopharmaceutical company discovering and developing innovative multi-functional protein-based therapeutics including bi-specific antibodies and drug conjugates for the treatment of cancer, and Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) announced today that they have entered into a cross-licensing and collaboration agreement to develop proprietary cancer immuno-oncology products.
Arbutus Reports Interim Multi-Dose Results from Phase II Clinical Trial of ARB-1467 in Patients with Chronic HBV Infection
VANCOUVER, British Columbia and DOYLESTOWN, Pa., Sept. 29, 2016 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq:ABUS), an industry-leading hepatitis B virus (HBV) therapeutic solutions company, today reported interim results from the first two cohorts of the ongoing ARB-1467 Phase II multi-dose clinical trial in chronically infected HBV patients.
FDA approves Medtronic's 'artificial pancreas,' the world's first
September 28, 2016 |By Amirah Al Idrus | On Wednesday, the FDA approved Medtronic's hybrid closed-loop system, the world's first "artificial pancreas." The agency nod comes months ahead of the spring approval that the company had been expecting.
Ex-Novartis consumer vet takes Glaxo JV reins from CEO-bound Walmsley
September 29, 2016 | by Carly Helfand | GlaxoSmithKline CEO-to-be Emma Walmsley will leave a chair vacant at the top of its key consumer health JV, and stepping in to take it is Brian McNamara, a Novartis exec who joined the venture with last year's asset swap.
Alzheimer's and other diseases could be linked to contagious bacteriophages
September 28, 2016 | by Michael Gibney | New research from the Human Microbiology Institute has shown that many diseases, from Alzheimer's to cancer and others, could be linked to bacterial viruses, a finding that could indicate those diseases are in fact contagious.
Acne sufferers' cells may be protected against ageing
September 28, 2016 | King`s College London > Scientistsat King's College London have found that people who have previously suffered from acne are likely to have longer telomeres (the protective repeated nucleotides found at the end of chromosomes) in their white blood cells, meaning their cells could be better protected against ageing.
September 29, 2016 | James GallagherHealth and science reporter, BBC News website | A 10th of children have a "monkey-like" immune system that stops them developing Aids, a study suggests. The study, in Science Translational Medicine, found the children's immune systems were "keeping calm", which prevented them being wiped out.
Free Webcast of "Demystifying the US Healthcare and Life Sciences Market September 30, 2016
In collaboration with MaRS and in partnership with the Trade Commissioner Service (TCS) of Global Affairs Canada, EDC invites you to a Life Sciences and Health Care webcast, live streamed from Toronto, Ontario.
Date: September 30, 2016
Time: 09:00 AM EDT
PANEL DISCUSSION & Q&A
9:00 AM - 11:00 AM
Facilitated by Dr. Jason Field, Executive Director of Life Sciences Ontario, the panel discussion will focus on the following topic: "Demystifying the US Healthcare and Life Sciences Market". The panel members will provide insight into some of the challenges and opportunities faced by Canadian companies in the Life Sciences and Healthcare sectors that are targeting the US market, including discussions on the regulatory environment and reimbursement.
*Pravin Chaturvedi, President & Chief Executive Officer of Pivot Pharmaceuticals, Inc.
*Jessica Holmes, Executive Director of Reimbursement of Argenta Advisors, Inc.
*Antonio Lopes, Global Accounts Director, Export Development Canada
*Matt Pasiuk, Canadian Trade Commissioner in San Francisco for Foreign Affairs and Trade Development Canada
*Kevin Talbot, Co-Founder & Managing Partner of Relay Ventures
*Lawrence Vernaglia, Partner & Chair, Health Care Practice Group, Foley and Lardner, Venture Partner at Converge Venture Partners
Introducing the UPS® Members Benefit Program for Life Sciences BC Members
Take advantage of the UPS Members Benefit Program and save on a variety of UPS services! You'll receive 30% off small package shipments within Canada, to the U.S. and to worldwide destinations, 25% off imports into Canada, discounts starting at 70% off freight shipments and more.
Through your Life Sciences BC membership, you can save 10%-20% off the web price of wide range of office supplies from Grand & Toy! Plus, there is no charge for next-business-day delivery on orders over $50 to most Canadian locations. (Some conditions apply.)
Corporate discounts & group rates at The Listel Hotel
The Listel Hotel, a four star boutique hotel, is known for its enthusiastic service and commitment to high design and guest comfort. This intimate Robson street hotel boasts a perfect location with an award-winning restaurant Forage and gastro-pub Timber.